Loading clinical trials...
Loading clinical trials...
Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics
* The aim is to describe disease mechanisms of severe and cerebral malaria and identify new targets for adjunctive therapies. * Despite treatment between 10-30% of patients with severe malaria die. * Metabolic acidosis and cerebral malaria are major complications associated with mortality across all age groups. Still, their underlying pathogenesis remains incompletely understood. * Using a metabolomics approach, this study aims to characterise the spectrum of acids accumulating during acidosis, and investigate patterns of metabolic dysregulation associated with coma and seizures.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Chittagong Medical College Hospital (CMCH)
Chittagong, Bangladesh
Start Date
June 1, 2015
Primary Completion Date
September 1, 2017
Completion Date
September 1, 2017
Last Updated
June 20, 2018
840
ACTUAL participants
Observation
OTHER
Lead Sponsor
University of Oxford
Collaborators
NCT06601712
NCT07082205
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06635733